Express News | Moelis Appoints DR. Louise Mirrer as an Independent Member to Its Board of Directors
Moelis Analyst Ratings
Wells Fargo Initiates Coverage on Moelis & Company With Equal Weight Rating, $70 Price Target
KBW Maintains Moelis & Co(MC.US) With Hold Rating, Raises Target Price to $70
Novo Nordisk Stock Rises After Study Finds Obesity Drug Safe For Kids
Goldman Sachs Maintains Moelis & Co(MC.US) With Hold Rating, Raises Target Price to $66
Ulta Beauty Stock Dives After Earnings Miss. Why Berkshire Hathaway Sees Potential.
Moelis Insider Sold Shares Worth $7,254,445, According to a Recent SEC Filing
Moelis & Co(MC.US) Officer Sells US$7.25 Million in Common Stock
Moelis & Co Upgrades Gold Road to Buy From Hold; Price Target Is AU$2.10
Form 144 | Moelis & Co(MC.US) Officer Proposes to Sell 7.25 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 30, $Moelis & Co(MC.US)$ Officer KEN D MOELIS intends to sell 105.31K shares of its common stock on Jul 30, with a total market value of approximately $7.25 million.
Seaport Global Initiates Moelis & Co(MC.US) With Hold Rating
Morgan Stanley Maintains Moelis & Co(MC.US) With Sell Rating, Maintains Target Price $61
UBS Maintains Moelis & Co(MC.US) With Sell Rating, Raises Target Price to $54
Moelis & Co | 10-Q: Q2 2024 Earnings Report
Keefe, Bruyette & Woods Adjusts Price Target on Moelis to $60 From $54, Maintains Market Perform
UBS Adjusts Moelis & Company Price Target to $54 From $50, Maintains Sell Rating
Express News | Moelis & Co : UBS Raises Target Price to $54 From $50
Moelis & Co. Price Target Raised to $51.00/Share From $50.00 by JP Morgan
JP Morgan Maintains Neutral on Moelis, Raises Price Target to $51